Skip to content

Synchron System Hemoglobin Alc Reagent

by Beckman Instruments, Inc. 510(k)

Active United States

510(k) K973696

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK973696 Date24 Nov 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

2 recalls · FDA

    • Terminated Z-1156-04 FDA Unclassified (pre-2012) initiated 18 Aug 2003 on shared 510(k) K973696

    Values for ApoB were not properly assigned on the package insert. Customers were not able to recover the analyte within the stated values.

    • Terminated Z-1155-04 FDA Unclassified (pre-2012) initiated 15 Aug 2003 on shared 510(k) K973696

    LDL Cholesterol component in controls are unstable.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Specification

510(k)

510(k) Number
FDA Product Code
LCP
Device Class
Class II
Regulation
21 CFR Part 864.7470
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Synchron System Hemoglobin A1c Reagent is an in vitro diagnostic assay designed to measure glycosylated hemoglobin (HbA1c) levels in human whole blood. It functions as a reagent for use with the Synchron Clinical Systems to quantify HbA1c concentration as a percentage of total hemoglobin, aiding in the diagnosis and management of diabetes.

This reagent is intended for clinical laboratory use and is supplied as a kit for processing whole blood samples. It is classified as a Class II medical device under FDA regulations (864.7470) and holds a 510(k) clearance for substantial equivalence in hematology applications. The product is not described as single-use or reusable, nor are MRI safety or sterility specifications provided in the available data.

Other devices from Beckman Instruments, Inc.

See all devices from Beckman Instruments, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Synchron System Hemoglobin A1c Reagent used for in a clinical setting?

    The Synchron System Hemoglobin A1c Reagent is designed to measure glycosylated hemoglobin (HbA1c) levels in human whole blood. HbA1c testing helps clinicians diagnose and monitor diabetes by quantifying the percentage of hemoglobin bound to glucose over time, providing insight into long-term blood sugar control.

  • How is the Synchron System Hemoglobin A1c Reagent supplied, and is it intended for single-use or reuse?

    The reagent is supplied as a kit for processing whole blood samples, intended for use with the Synchron Clinical Systems. The data does not specify whether it is single-use or reusable, so its intended use should be confirmed with the manufacturer or local protocols.

  • What regulatory pathway was followed for the FDA clearance of this device?

    The Synchron System Hemoglobin A1c Reagent received FDA clearance through a 510(k) submission, classified as a Traditional pathway. It was determined to be substantially equivalent to a predicate device under the Hematology advisory committee (HE) and falls under FDA classification 864.7470 for glycosylated hemoglobin assays.

  • Are there multiple versions or models of this reagent, and how would I identify the correct one for my lab?

    The data lists multiple FEI numbers (e.g., 3043654757, 3003422726) associated with this reagent, which may correspond to different lot codes or configurations. To ensure compatibility, verify the exact FEI number or registration number on your kit against your lab’s inventory or consult Beckman Instruments for model-specific guidance.